§ 65-4111 — Substances included in schedule IV

Kansas § 65-4111

• Jurisdiction: Kansas
• Ch. 65: PUBLIC HEALTH
• Art. 41: CONTROLLED SUBSTANCES

Text

(a) The controlled substances listed in this section are included in schedule IV and the number set forth opposite each drug or substance is the DEA controlled substances code that has been assigned to it.
(b) Any material, compound, mixture or preparation that contains any quantity of the following substances including its salts, isomers and salts of isomers whenever the existence of such salts, isomers and salts of isomers is possible within the specific chemical designation and having a potential for abuse associated with a depressant effect on the central nervous system:
(1) Alprazolam 2882
(2) Barbital 2145
(3) Brexanolone 2400
(4) Bromazepam 2748
(5) Camazepam 2749
(6) Carisoprodol 8192
(7) Chloral betaine 2460
(8) Chloral hydrate 2465
(9) Chlordiazepoxide 2744
(10) Clobazam 2751
(11) Clonazepam 2737
(12) Clorazepate 2768
(13) Clotiazepam 2752
(14) Cloxazolam 2753
(15) Daridorexant 2410
(16) Delorazepam 2754
(17) Diazepam 2765
(18) Dichloralphenazone 2467
(19) Estazolam 2756
(20) Ethchlorvynol 2540
(21) Ethinamate 2545
(22) Ethyl loflazepate 2758
(23) Fludiazepam 2759
(24) Flunitrazepam 2763
(25) Flurazepam 2767
(26) Fospropofol 2138
(27) Halazepam 2762
(28) Haloxazolam 2771
(29) Ketazolam 2772
(30) Lemborexant 2245
(31)Loprazolam 2773
(32)Lorazepam 2885
(33) Lormetazepam 2774
(34) Mebutamate 2800
(35) Medazepam 2836
(36) Meprobamate 2820
(37) Methohexital 2264
(38) Methylphenobarbital (mephobarbital) 2250
(39) Midazolam 2884
(40) Nimetazepam 2837
(41) Nitrazepam 2834
(42) Nordiazepam 2838
(43) Oxazepam 2835
(44) Oxazolam 2839
(45) Paraldehyde 2585
(46) Petrichloral 2591
(47) Phenobarbital 2285
(48) Pinazepam 2883
(49) Prazepam 2764
(50) Quazepam 2881
(51) Remimazolam 2846
(52) Temazepam 2925
(53) Tetrazepam 2886
(54) Triazolam 2887
(55) Zolpidem 2783
(56) Zaleplon 2781
(57) Zopiclone 2784
(58) Alfaxalone. 2731
(59) Suvorexant 2223
(c) Any material, compound, mixture or preparation that contains any quantity of lorcaserin (1625), including its salts, isomers and salts of such isomers, whenever the existence of such salts, isomers and salts of isomers is possible (21 U.S.C. § 812; 21 C.F.R. § 1308.14).
(d) Unless specifically excepted or unless listed in another schedule, any material, compound, mixture or preparation that contains any quantity of the following substances having a stimulant effect on the central nervous system, including its salts, isomers (whether optical, position or geometric) and salts of such isomers whenever the existence of such salts, isomers and salts of isomers is possible within the specific chemical designation:
(1) Cathine ((+)-norpseudoephedrine) 1230
(2) Diethylpropion 1610
(3) Fencamfamin 1760
(4) Fenproporex 1575
(5) Mazindol 1605
(6) Mefenorex 1580
(7) Pemoline (including organometalliccomplexes and chelates thereof) 1530
(8) Phentermine 1640
The provisions of subsection (d)(8) shall expire on the date phentermine and its salts and isomers are removed from schedule IV of the federal controlled substances act (21 U.S.C. § 812; 21 C.F.R. § 1308.14).
(9) Pipradrol 1750
(10) Serdexmethylphenidate 1729
(11) SPA((-)-1-dimethylamino-1, 2-diphenylethane) 1635
(12) Sibutramine 1675
(13) Solriamfetol (2-amino-3-phenylpropyl carbamate; benzenepropanol, beta-amino-, carbamate (ester)) 1650
(14) Mondafinil 1680
(e) Unless specifically excepted or unless listed in another schedule, any material, compound, mixture or preparation that contains any quantity of the following, including salts thereof:
(1) Pentazocine 9709
(2) Butorphanol (including its optical isomers) 9720
(3) Eluxadoline (5-[[[(2S)-2-amino-3-[4-aminocarbonyl)-2,6-dimethylphenyl]-1-oxopropyl][(1S)-1-(4-phenyl-1H-imidazol-2-yl)ethyl]amino]methyl]-2-methoxybenzoic acid) (including its optical isomers) and its salts, isomers, and salts of isomers 9725
(f) Unless specifically excepted or unless listed in another schedule, any material, compound, mixture or preparation containing any of the following narcotic drugs, or their salts calculated as the free anhydrous base or alkaloid, in limited quantities as set forth below:
(1) Not more than 1 milligram of difenoxin and not less than 25 micrograms of atropine sulfate per dosage unit 9167
(2) Dextropropoxyphene (alpha-(+)-4-dimethylamino-1, 2-diphenyl-3-methyl-2-propion-oxybutane) 9278
(3) 2-[(dimethylamino)methyl]-1-(3-methoxyphenyl)cyclohexanol, its salts, optical and geometric isomers and salts of these isomers (including tramadol) 9752
(g) Butyl nitrite and its salts, isomers, esters, ethers or their salts.
(h) The board may except by rule and regulation any compound, mixture or preparation containing any depressant substance listed in subsection (b) from the application of all or any part of this act if the compound, mixture or preparation contains one or more active medicinal ingredients not having a depressant effect on the central nervous system, and if the admixtures are included therein in combinations, quantity, proportion or concentration that vitiate the potential for abuse of the substances that have a depressant effect on the central nervous system.

Legislative History

L. 1972, ch. 234, § 11; L. 1974, ch. 258, § 5; L. 1978, ch. 257, § 3; L. 1979, ch. 204, § 1; L. 1982, ch. 269, § 5; L. 1985, ch. 220, § 4; L. 1986, ch. 241, § 3; L. 1989, ch. 200, § 4; L. 1990, ch. 231, § 1; L. 1991, ch. 199, § 4; L. 1993, ch. 70, § 2; L. 1996, ch. 257, § 2; L. 1998, ch. 190, § 1; L. 2000, ch. 108, § 4; L. 2001, ch. 171, § 5; L. 2011, ch. 83, § 6; L. 2012, ch. 107, § 8; L. 2014, ch. 79, § 3; L. 2015, ch. 27, § 4; L. 2016, ch. 95, § 4; L. 2017, ch. 57, § 6; L. 2022, ch. 99, § 5; L. 2024, ch. 67, § 6; July 1.